CO6210733A2 - Asociacion de compuestos inhibidores de melanogenesis y su uso en cosmeticos y dermatologia - Google Patents
Asociacion de compuestos inhibidores de melanogenesis y su uso en cosmeticos y dermatologiaInfo
- Publication number
- CO6210733A2 CO6210733A2 CO09074062A CO09074062A CO6210733A2 CO 6210733 A2 CO6210733 A2 CO 6210733A2 CO 09074062 A CO09074062 A CO 09074062A CO 09074062 A CO09074062 A CO 09074062A CO 6210733 A2 CO6210733 A2 CO 6210733A2
- Authority
- CO
- Colombia
- Prior art keywords
- cosmetic
- inhibitor
- vitamin
- receptor antagonist
- composition according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1.- Una combinación que comprende por lo menos un antagonista del receptor de MC1-R, un inhibidor de tirosinasa derivado de vitamina C y un inhibidor de transferencia de melanosoma a los queratinocitos, caracterizada porque el antagonista del receptor de MC1-R es MELANOSTATINE® 5. 2.- La combinación de acuerdo con la reivindicación 1, caracterizada porque el inhibidor de tirosinasa derivado de vitamina C es 2-glucósido de ácido ascórbico. 3.- La combinación de acuerdo con cualquiera de las reivindicaciones anteriores, caracterizada porque el inhibidor de transferencia de melanosoma a los queratinocitos es nicotinamida. 4.- Una composición cosmética y/o dermatológica que comprende una combinación de acuerdo con cualquiera de las reivindicaciones anteriores en un portador cosmética o dermatológicamente aceptable. 5.- La composición cosmética y/o dermatológica de acuerdo con la reivindicación 4, caracterizada porque comprende: - 0.01% a 5% de inhibidor de transferencia de melanosoma, - 0.01% a 5% de inhibidor de tirosinasa derivado de vitamina C, - 0.1 a 40 ppm de antagonista del receptor de MC1-R. 6.- La composición cosmética y/o dermatológica de acuerdo con la reivindicación 5, caracterizada porque comprende: - 0.01% a 5% de niconamida, - 0.01% a 5% de 2-glucósido de ácido ascórbico, - 0.1 a 40 ppm de MELANOSTATINE®.7.- El uso cosmético de una composición de acuerdo con cualquiera de las reivindicaciones 4 a 6, para prevenir y/o tratar la aparición de pigmentación excesiva de la piel y/o brotes corporales superficiales.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0700279A FR2911280B1 (fr) | 2007-01-16 | 2007-01-16 | Association de composes inhibiteurs de la melanogenese et leurs utilisations en cosmetique et en dermatologie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6210733A2 true CO6210733A2 (es) | 2010-10-20 |
Family
ID=38472980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO09074062A CO6210733A2 (es) | 2007-01-16 | 2009-07-16 | Asociacion de compuestos inhibidores de melanogenesis y su uso en cosmeticos y dermatologia |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20100055059A1 (es) |
| EP (1) | EP2109440B1 (es) |
| JP (1) | JP5358456B2 (es) |
| CN (1) | CN101631532A (es) |
| BR (1) | BRPI0806775B1 (es) |
| CA (1) | CA2675463A1 (es) |
| CO (1) | CO6210733A2 (es) |
| EA (1) | EA016034B1 (es) |
| FR (1) | FR2911280B1 (es) |
| IL (1) | IL199830A0 (es) |
| MA (1) | MA31083B1 (es) |
| MX (1) | MX2009007575A (es) |
| MY (1) | MY162582A (es) |
| TN (1) | TN2009000297A1 (es) |
| WO (1) | WO2008107533A2 (es) |
| ZA (1) | ZA200904399B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101389529B1 (ko) | 2012-02-03 | 2014-04-29 | 주식회사 스킨앤테크 | 가용화된 4-메톡시칼콘을 함유하는 피부 미백 조성물 및 이의 제조방법 |
| WO2014088296A1 (ko) * | 2012-12-04 | 2014-06-12 | 재단법인 경기과학기술진흥원 | 산유자 추출물을 이용한 피부 미백용 조성물 |
| EP2969030B1 (en) * | 2013-03-12 | 2021-01-13 | Avon Products, Inc. | A topical lightening composition and methods of use thereof |
| EP2875806A1 (en) | 2013-11-20 | 2015-05-27 | Infinitec Activos, S.L. | Targeted capsules for the delivery of whitening agents in the skin |
| JP6820645B2 (ja) * | 2014-02-26 | 2021-01-27 | 共栄化学工業株式会社 | 美白用組成物及び化粧料 |
| US9949913B2 (en) * | 2016-03-14 | 2018-04-24 | Jan Marini Skin Research | Luminate face lotion |
| CN108324590A (zh) * | 2018-05-17 | 2018-07-27 | 云南白药清逸堂实业有限公司 | 一种美白护理液及其制备方法 |
| EP3599046A1 (de) | 2018-07-27 | 2020-01-29 | FRONIUS INTERNATIONAL GmbH | Lichtbogenschweissverfahren mit einem abschmelzenden schweissdraht |
| JP2021004215A (ja) * | 2019-06-27 | 2021-01-14 | 小林製薬株式会社 | Ｍｃ１ｒ発現抑制剤 |
| CN111450250A (zh) * | 2020-03-12 | 2020-07-28 | 中南大学湘雅三医院 | Enst00000606533的增强剂或抑制剂在制备治疗色素性皮肤病药物中的应用 |
| FR3137284A1 (fr) * | 2022-06-29 | 2024-01-05 | Laboratoires Nigy | Composition pour la prevention et le traitement de l’hyperpigmentation de la peau a base de niacinamide ou de l’un de ses derives et d’un extrait d’algue cystoseira |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006102289A2 (en) * | 2005-03-23 | 2006-09-28 | Mary Kay Inc. | Skin lightening compositions |
| US20060263309A1 (en) * | 2005-05-17 | 2006-11-23 | Bissett Donald L | Regulation of mammalian keratinous tissue using personal care compositions comprising tetrahydrocurcumin |
| US9265792B2 (en) * | 2005-11-16 | 2016-02-23 | Patricia A. Riley | Integument cell regeneration formulation |
-
2007
- 2007-01-16 FR FR0700279A patent/FR2911280B1/fr not_active Expired - Fee Related
-
2008
- 2008-01-15 EP EP08761761.9A patent/EP2109440B1/fr active Active
- 2008-01-15 EA EA200970688A patent/EA016034B1/ru unknown
- 2008-01-15 BR BRPI0806775A patent/BRPI0806775B1/pt active IP Right Grant
- 2008-01-15 MX MX2009007575A patent/MX2009007575A/es not_active Application Discontinuation
- 2008-01-15 CN CN200880001990A patent/CN101631532A/zh active Pending
- 2008-01-15 CA CA002675463A patent/CA2675463A1/fr not_active Abandoned
- 2008-01-15 MY MYPI20092788A patent/MY162582A/en unknown
- 2008-01-15 JP JP2009545969A patent/JP5358456B2/ja active Active
- 2008-01-15 US US12/522,261 patent/US20100055059A1/en not_active Abandoned
- 2008-01-15 WO PCT/FR2008/000040 patent/WO2008107533A2/fr active Application Filing
-
2009
- 2009-06-23 ZA ZA200904399A patent/ZA200904399B/xx unknown
- 2009-07-03 MA MA32071A patent/MA31083B1/fr unknown
- 2009-07-10 TN TNP2009000297A patent/TN2009000297A1/fr unknown
- 2009-07-13 IL IL199830A patent/IL199830A0/en unknown
- 2009-07-16 CO CO09074062A patent/CO6210733A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EA200970688A1 (ru) | 2009-12-30 |
| BRPI0806775B1 (pt) | 2016-12-06 |
| JP5358456B2 (ja) | 2013-12-04 |
| TN2009000297A1 (fr) | 2010-12-31 |
| ZA200904399B (en) | 2010-07-28 |
| WO2008107533A2 (fr) | 2008-09-12 |
| FR2911280A1 (fr) | 2008-07-18 |
| FR2911280B1 (fr) | 2012-06-22 |
| MA31083B1 (fr) | 2010-01-04 |
| CA2675463A1 (fr) | 2008-09-12 |
| JP2010515768A (ja) | 2010-05-13 |
| MX2009007575A (es) | 2009-07-22 |
| EA016034B1 (ru) | 2012-01-30 |
| EP2109440B1 (fr) | 2016-01-13 |
| IL199830A0 (en) | 2010-04-15 |
| BRPI0806775A2 (pt) | 2011-09-13 |
| WO2008107533A3 (fr) | 2009-04-09 |
| CN101631532A (zh) | 2010-01-20 |
| EP2109440A2 (fr) | 2009-10-21 |
| MY162582A (en) | 2017-06-30 |
| US20100055059A1 (en) | 2010-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6210733A2 (es) | Asociacion de compuestos inhibidores de melanogenesis y su uso en cosmeticos y dermatologia | |
| BRPI0509372A (pt) | composição, produto de clareamento da pele, métodos de inibir a produção de melanina, de aumentar a relação de melanina clara para a melanina escura na pele de um mamìfero, e de inibir, na pele de um indivìduo, o transporte da melanina dos melanócitos para os queratinócitos, e, uso de uma composição | |
| WO2005102252A3 (de) | Haut- und/oder haarmittel enthaltend verbindungen mit isoprenoider struktur | |
| BR112015020196A2 (pt) | uma composição tópica para clareamento e métodos de uso da mesma | |
| MX2009010535A (es) | Protector solar y composiciones para el cuidado personal que comprenden un copolimero seleccionado. | |
| EP2144608A4 (en) | SUN PROTECTION COMPOSITIONS AND METHODS | |
| EP2146688A4 (en) | COSMETIC COMPOSITION FOR LIGHTING UP THE SKIN WITH MAGNOLIA SIEBOLDII EXTRACT AS AN ACTIVE SUBSTANCE | |
| EA200970154A1 (ru) | Косметические или дерматологические препараты, содержащие n-ацетилцистеин | |
| FR2933608B1 (fr) | Nouvelle utilisation d'un extrait de grande mauve agent hydratant, et composition cosmetique le contenant. | |
| MX2009010484A (es) | Composiciones de protectores solares que comprenden un terpolimero aleatorio. | |
| HK1166737A1 (en) | Topical cosmetic compositions for treating or preventing cellulite | |
| WO2012116990A3 (en) | Novel use | |
| WO2013087631A3 (en) | Oxidation dye composition comprising a particular coupler in a medium rich in fatty substances, and processes and device suitable therefor | |
| WO2014090525A3 (de) | Reduzierung des ammoniakgeruchs in mitteln zum oxidativen färben und/oder aufhellen von keratinischen fasern | |
| MX345695B (es) | Heterociclocarbonilaminotiazoles, preparaciones cosmeticas o dermatologicas que contienen los mismos y su uso para el control y la profilaxis de pigmentacion indeseada de la piel. | |
| AR055453A1 (es) | Uso de la idebenona en una composicion destinada a ser aplicada sobre la piel y composicion que la comprende | |
| FR2926220B1 (fr) | Utilisation cosmetique d'un extrait de la plante pancratium maritimum comme agent cosmetique antioxydant et/ou inhibiteur de la melanogenese | |
| FR2973226B1 (fr) | Utilisation de composes (ethoxy-hydroxyphenyl)alkylcetone ou ethoxyhydroxyalkylphenol pour traiter la peau grasse | |
| CO6241129A2 (es) | Extractos botanicos de licor vegetal de palma de aceite para aplicaciones cosmeticas | |
| WO2003090688A3 (en) | Enhancement of human epidermal melanogenesis | |
| CO6450611A2 (es) | Uso de delta-tocoferil-carbohidrato como agente despigmentante | |
| AR056018A1 (es) | Una composicion para usar en la piel | |
| ATE372108T1 (de) | Hautpflegeprodukt enthaltend ursolsäure und ginkgo-extrakt | |
| FR2903907B1 (fr) | Utilisation d'un extrait de gleditsia en cosmetique et en dermatologie. | |
| TW200743496A (en) | A topical formula for skin de-pigmentation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn |